Article Text

Download PDFPDF
Orbital bone infarction masquerading as preseptal cellulitis in a child with sickle beta-thalassaemia
  1. Furat Alrajhi1,
  2. Hanan Jamjoom1,
  3. Suzan Alharbi2 and
  4. Amir Alrajhi1
  1. 1Ophthalmology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia
  2. 2Ophthalmology, Jeddah Eye Hospital, Jeddah, Saudi Arabia
  1. Correspondence to Dr Furat Alrajhi; dr.furat{at}hotmail.com

Abstract

Although several ophthalmic manifestations of sickle cell disease (SCD) are common, orbital bone infarction is rare. Orbital bones have less bone marrow creating an unlikely place to develop infarction. However, having a patient with SCD presenting with periorbital swelling should warrant imaging to rule out bone infarction. We present a case of a child with sickle beta-thalassaemia who was misdiagnosed with preseptal cellulitis in the right eye. Later upon review of the subtle signs of bone infarction in imaging, she was discovered to have orbital bone infarction.

  • Haematology (incl blood transfusion)
  • Ophthalmology
  • Sickle cell disease

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors FA planned and contributed to the write-up of the manuscript, liaised with radiology for MRI of the patient and was the corresponding author. HJ contributed to reviewing and editing the final draft. SA and AA contributed to collecting the patient data, reviewing the literature and the process of publication.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • © BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.